4//SEC Filing
REPLIGEN CORP 4
Accession 0001140361-17-012940
$RGENCIK 0000730272operating
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:41 PM ET
Size
13.9 KB
Accession
0001140361-17-012940
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
Benjamin Howard
Other
Transactions
- Exercise/Conversion
Common Stock
2017-03-20$15.91/sh+4,968$79,041→ 36,124 total - Sale
Common Stock
2017-03-20$34.61/sh−4,968$171,944→ 31,156 total - Sale
Common Stock
2017-03-20$34.63/sh−7,248$251,010→ 23,908 total - Exercise/Conversion
Common Stock
2017-03-20$6.23/sh+10,000$62,300→ 33,908 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-03-20−4,968→ 0 totalExercise: $15.91Exp: 2024-02-27→ Common Stock (4,968 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2017-03-20−10,000→ 0 totalExercise: $6.23Exp: 2023-02-28→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]$34.6103 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.475 to $34.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]$34.6316 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.475 to $34.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]This option is currently exercisable.
Documents
Issuer
REPLIGEN CORP
CIK 0000730272
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000730272
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:41 PM ET
- Size
- 13.9 KB